Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on 3 Aminobenzo[d]isothiazole. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel catalyst-free synthesis of 3-aminobenzo[d]isothiazole derivatives using elemental sulfur. Offers cost reduction and scalable pharmaceutical intermediate manufacturing.
Patent CN102040564B reveals a safe, high-yield nucleophilic substitution route for 3-aminobenzo[d]isothiazole, offering significant cost reduction and supply chain stability for pharma manufacturing.